Active Ingredient: MELOXICAM
Proprietary Name: QMIIZ ODT
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 7.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N211210
Product Number: 001
Approval Date: Oct 19, 2018
Applicant Holder Full Name: TERSERA THERAPEUTICS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
